{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:23:44Z","timestamp":1740029024420,"version":"3.37.3"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1124\/jpet.301.3.1151","type":"journal-article","created":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T18:37:30Z","timestamp":1042223850000},"page":"1151-1156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Intimatan Prevents Arterial and Venous Thrombosis in a Canine Model of Deep Vessel Wall Injury"],"prefix":"10.1016","volume":"301","author":[{"given":"James K.","family":"Hennan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Ting","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ardamanpal K.","family":"Shergill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan D.","family":"Cardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedict R.","family":"Lucchesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.301.3.1151_bib1","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1182\/blood.V70.6.1858.1858","article-title":"Dermatan sulfate induces plasminogen activator release in the perfused rat hindquarters.","volume":"70","author":"Abbadini","year":"1987","journal-title":"Blood"},{"key":"10.1124\/jpet.301.3.1151_bib2","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1074\/jbc.274.10.6226","article-title":"Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II.","volume":"274","author":"Becker","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.301.3.1151_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-4899-2444-5_24","article-title":"Pharmacokinetics of heparin and of dermatan sulfate: clinical implications.","volume":"313","author":"Boneu","year":"1992","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/jpet.301.3.1151_bib4","first-page":"575","article-title":"Effect of heparin and CL-0313 on complement activation in vitro and thrombin generation during cardiopulmonary bypass (CPB) in vivo (Abstract).","volume":"26","author":"Brister","year":"1996","journal-title":"Haemostasis"},{"key":"10.1124\/jpet.301.3.1151_bib5","first-page":"4","article-title":"Surface-bound thrombin inhibition and intimal hyperplasia following vessel wall injury: relative effects of heparin and Intimatan (Abstract).","volume":"28","author":"Buchanan","year":"1998","journal-title":"Haemostasis"},{"key":"10.1124\/jpet.301.3.1151_bib6","first-page":"81","article-title":"A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding.","volume":"111","author":"Buchanan","year":"1999","journal-title":"Wien Klin Wochenschr"},{"key":"10.1124\/jpet.301.3.1151_bib7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0049-3848(00)00276-0","article-title":"Anticoagulant and antithrombotic effects of Intimatan, a heparin cofactor II agonist.","volume":"99","author":"Buchanan","year":"2000","journal-title":"Thromb Res"},{"key":"10.1124\/jpet.301.3.1151_bib8","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-0037-1616149","article-title":"Selective and sustained inhibition of surface-bound thrombin activity by intimatan\/heparin cofactor II and its relevance to assessing systemic anticoagulation in vivo, ex vivo and in vitro.","volume":"86","author":"Buchanan","year":"2001","journal-title":"Thromb Haemostasis"},{"key":"10.1124\/jpet.301.3.1151_bib9","first-page":"759","article-title":"Dermatan sulfate and the prevention of experimental venous thrombosis.","volume":"37","author":"Desnoyers","year":"1989","journal-title":"Pathol Biol"},{"key":"10.1124\/jpet.301.3.1151_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1749-6632.1986.tb34563.x","article-title":"Thrombin.","volume":"485","author":"Fenton","year":"1986","journal-title":"Ann NY Acad Sci"},{"key":"10.1124\/jpet.301.3.1151_bib11","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1055\/s-0037-1614856","article-title":"Dermatan sulfate and low molecular weight heparin enhance the anticoagulant action of activated protein C.","volume":"82","author":"Fernandez","year":"1999","journal-title":"Thromb Haemostasis"},{"key":"10.1124\/jpet.301.3.1151_bib12","first-page":"103","article-title":"Pharmacokinetics of low-molecular-weight heparins Fragmin D in dogs.","volume":"113","author":"Grebe","year":"2000","journal-title":"Berl Muench Tieraerztl Wochenschr"},{"key":"10.1124\/jpet.301.3.1151_bib13","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/hc3301.092790","article-title":"Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.","volume":"104","author":"Hennan","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/jpet.301.3.1151_bib14","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1073\/pnas.86.10.3619","article-title":"Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.","volume":"86","author":"Hogg","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.301.3.1151_bib15","doi-asserted-by":"crossref","first-page":"26088","DOI":"10.1074\/jbc.271.42.26088","article-title":"Binding of fibrin monomer and heparin to thrombin in a ternary complex alters the environment of the thrombin catalytic site, reduces affinity for hirudin, and inhibits cleavage of fibrinogen.","volume":"271","author":"Hogg","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.301.3.1151_bib16","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM199603143341102","article-title":"Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low molecular weight heparin administered at home.","volume":"334","author":"Koopman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.301.3.1151_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1055\/s-0038-1648947","article-title":"The influence of fibrinogen and fibrin on thrombin generation\u2014evidence for feedback activation of the clotting system by clot bound thrombin.","volume":"72","author":"Kumar","year":"1994","journal-title":"Thromb Haemostasis"},{"key":"10.1124\/jpet.301.3.1151_bib18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199603143341101","article-title":"A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.","volume":"334","author":"Levine","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.301.3.1151_bib19","doi-asserted-by":"crossref","first-page":"27597","DOI":"10.1074\/jbc.274.39.27597","article-title":"Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.","volume":"274","author":"Liaw","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.301.3.1151_bib20","doi-asserted-by":"crossref","first-page":"20959","DOI":"10.1074\/jbc.M010584200","article-title":"Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor II in the presence of dermatan sulfate but not heparin.","volume":"276","author":"Liaw","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.301.3.1151_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-0038-1656309","article-title":"Subcutaneous low molecular weight heparin in the treatment of deep vein thrombosis: a Polish multicenter trial.","volume":"68","author":"Lopaciuk","year":"1992","journal-title":"Thromb Haemostasis"},{"key":"10.1124\/jpet.301.3.1151_bib22","series-title":"Thrombosis and Hemorrhage","first-page":"13","article-title":"Prothrombinase generation and the regulation of coagulation","author":"Rosenburg","year":"1994"},{"key":"10.1124\/jpet.301.3.1151_bib23","series-title":"Thrombosis and Hemorrhage","first-page":"3","article-title":"Coagulation cascade: an overview","author":"Schafer","year":"1994"},{"key":"10.1124\/jpet.301.3.1151_bib24","doi-asserted-by":"crossref","first-page":"21A","DOI":"10.1016\/S0735-1097(97)83803-X","article-title":"Differential inhibition of neointimal thickening after balloon injury in the rabbit aorta by glycosaminoglycans.","volume":"31","author":"Schwartz","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.301.3.1151_bib25","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1016\/S0021-9258(18)32276-2","article-title":"Activation of heparin cofactor II by dermatan sulfate.","volume":"258","author":"Tollefsen","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.301.3.1151_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI114723","article-title":"Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.","volume":"86","author":"Weitz","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.301.3.1151_bib27","unstructured":"Yang LY, Cancel QV, Schwartz D, Abendschien D, Eisenberg PR, and Van Gorp CL (1999) Intimatan, a heparin cofactor II catalyst, inhibits vessel wall thrombogenicity and intimal hyperplasia more effectively than heparin (Abstract). Thromb Haemostasis Int Soc Thromb Haemostasis Suppl:414."}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524357209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524357209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.301.3.1151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:21:25Z","timestamp":1740007285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524357209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["S0022356524357209"],"URL":"https:\/\/doi.org\/10.1124\/jpet.301.3.1151","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2002,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intimatan Prevents Arterial and Venous Thrombosis in a Canine Model of Deep Vessel Wall Injury","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.301.3.1151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}